Studies suggest that TRIB2 overexpression negatively regulates the activity of the WNT signaling pathway and inhibits WNT-mediated transcriptional activity in hepatocellular carcinoma (HCC), which is closely related to patient prognosis (Wang et al., 2013). Here, TRIB2 is linked to hepatocellular carcinoma.